Patau, syndrome

(Trisomy 13)

Prevalence: between 1/8,000 and 1/15,000 births. Trisomy of chromosome 13: in 75 % of cases, trisomy is said to be "free."


In the other cases,

-        supernumerary chromosome is attached to another acrocentric chromosome  (13, 14, 15, 21, 22)

-        trisomy is caused by a reciprocal translocation between chromosome 13 and a non-acrocentric chromosome

-        or trisomy 13 presents as a mosaic with a highly variable phenotype.


The most common form of trisomy 13 combines:


-        holoprosencephaly, hypotonia

-        facial dysmorphism: hypotelorism (sometimes cyclopia), areas of aplasia cutis in the occipital region

-        ocular anomalies: microphthalmia or anophthalmia, coloboma

-        deafness,

-        convulsions,

-        cleft lip and/or palate,

-        polydactyly,

-        congenital heart disease in 80 % of cases: VSD, double-outlet right ventricle, cardiomyopathy, dextroposition

-        urogenital malformations: single kidney, hydronephrosis, polycystic kidney

-        spinal abnormalities: spina bifida occulta, tethered spinal cord, dural ectasia, pectus carnatum, scoliosis


Life expectancy is classically estimated to be less than 10 % at 1 year of age, which has often justified therapeutic abstention. Recent data in which children with trisomy 13 are compared with children with the same comorbidities show similar overall postoperative morbidity (but higher neurological morbidity) but higher postoperative mortality (RR: 4,43).


Anesthetic implications:

difficult intubation; increased sensitivity to the depressant effects of the opioids (1st choice: remifentanil ?); be cautious if a neuraxial block is planned


References : 


Updated: March 2023